MALDI-TOF MS联合实时抗菌药物管理干预对阳性血培养患者optimal治疗时间的影响
本研究为单中心前后对照准实验研究,评估MALDI-TOF MS单独与联合实时药师驱动的抗菌药物管理(AMS)干预对阳性血培养患者结局的影响。共纳入252份血培养(每组126份),联合干预组总体optimal治疗时间(TTOT)显著缩短(75.17 vs 43.06小时,P<0.001),并缩短总体住院时间(15.03 vs 9.02天,P=0.021)。
要点
- MALDI-TOF MS联合实时AMS干预可显著缩短阳性血培养患者的optimal治疗时间。
- 联合干预缩短总体住院时间,对革兰阳性感染和革兰阴性感染均有改善。
- 快速鉴定联合实时AMS干预比单独MALDI-TOF MS更有临床价值。
核心结论
- MALDI-TOF MS联合实时抗菌药物管理干预比单独MALDI-TOF MS更能改善阳性血培养患者的optimal治疗时间和住院结局。
研究设计与样本
- 单中心、前后对照、准实验研究,纳入252份阳性血培养,每组126份。
主要发现
- 联合干预组总体TTOT为43.06小时,对照组为75.17小时(P<0.001)。
- 联合干预组总体住院时间为9.02天,对照组为15.03天(P=0.021)。
- 革兰阳性感染TTOT为41.61 vs 64.04小时(P=0.082),住院时间10.31 vs 14.64天(P=0.002)。
- 革兰阴性感染TTOT为35.98 vs 71.83小时(P<0.001),住院时间7.90 vs 15.40天(P=0.027)。
临床怎么用
- 阳性血培养鉴定后应实时通知药师并反馈抗菌药物管理建议以缩短optimal治疗时间。
局限性
- 本研究为单中心前后对照准实验设计,可能存在时间偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) decreases the time to organism identification and improves clinical and financial outcomes. The purpose of this study was to evaluate the impact of MALDI-TOF MS alone versus MALDI-TOF MS combined with real-time, pharmacist-driven, antimicrobial stewardship (AMS) intervention on patient outcomes. This single-center, pre-post, quasiexperimental study evaluated hospitalized patients with positive blood cultures identified via MALDI-TOF MS combined with prospective AMS intervention compared to a control cohort with MALDI-TOF MS identification without AMS intervention. AMS intervention included: real-time MALDI-TOF MS pharmacist notification and prospective AMS provider feedback. The primary outcome was the time to optimal therapy (TTOT). A total of 252 blood cultures, 126 in each group, were included in the final analysis. MALDI-TOF MS plus AMS intervention significantly reduced the overall TTOT (75.17 versus 43.06 h; P < 0.001), the Gram-positive contaminant TTOT (48.21 versus 11.75 h; P < 0.001), the Gram-negative infection (GNI) TTOT (71.83 versus 35.98 h; P < 0.001), and the overall hospital length of stay (LOS; 15.03 versus 9.02 days; P = 0.021). The TTOT for Gram-positive infection (GPI) was improved (64.04 versus 41.61 h; P = 0.082). For GPI, the hospital LOS (14.64 versus 10.31 days; P = 0.002) and length of antimicrobial therapy 24.30 versus 18.97 days; P = 0.018) were reduced. For GNI, the time to microbiologic clearance (51.13 versus 34.51 h; P < 0.001), the hospital LOS (15.40 versus 7.90 days; P = 0.027), and the intensive care unit LOS (5.55 versus 1.19 days; P = 0.035) were reduced. To achieve optimal outcomes, rapid identification with MALDI-TOF MS combined with real-time AMS intervention is more impactful than MALDI-TOF MS alone.
引用
- Beganovic M, Costello M, Wieczorkiewicz SM, et al. Effect of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Alone versus MALDI-TOF MS Combined with Real-Time Antimicrobial Stewardship Interventions on Time to Optimal Antimicrobial Therapy in Patients with Positive Blood Cultures. J Clin Microbiol. 2017. PMID: 28228491. doi:10.1128/JCM.02245-16
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。